PD-1/PD-L1 Inhibitors versus Chemotherapy for Previously Treated Advanced Gastroesophageal Cancer: A Meta-Analysis of Randomized Controlled Trials

Patients with advanced gastroesophageal cancer refractory to the previous regimen of chemotherapy suffered from poor prognosis without many effective treatment options. Immune checkpoint inhibitors (ICIs) provide promising efficacy, but the relevant clinical trials have offered controversial data. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Maoxi, Zhong, Jinmin, Xue, Xiaozhu, Zeng, Yubing, Yue, Yuxi, Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463210/
https://www.ncbi.nlm.nih.gov/pubmed/34567113
http://dx.doi.org/10.1155/2021/3048974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463210/
https://www.ncbi.nlm.nih.gov/pubmed/34567113
http://dx.doi.org/10.1155/2021/3048974

Ejemplares similares